-+ 0.00%
-+ 0.00%
-+ 0.00%

Analysts Have Made A Financial Statement On GMO Payment Gateway, Inc.'s (TSE:3769) Full-Year Report

Simply Wall St·11/17/2026 01:28:54
Listen to the news

Last week, you might have seen that GMO Payment Gateway, Inc. (TSE:3769) released its yearly result to the market. The early response was not positive, with shares down 4.2% to JP¥8,175 in the past week. GMO Payment Gateway reported in line with analyst predictions, delivering revenues of JP¥95b and statutory earnings per share of JP¥331, suggesting the business is executing well and in line with its plan. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

earnings-and-revenue-growth
TSE:3769 Earnings and Revenue Growth November 17th 2026

Taking into account the latest results, the most recent consensus for GMO Payment Gateway from twelve analysts is for revenues of JP¥109.4b in 2027. If met, it would imply a notable 15% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to step up 17% to JP¥388. In the lead-up to this report, the analysts had been modelling revenues of JP¥110.5b and earnings per share (EPS) of JP¥400 in 2027. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

Check out our latest analysis for GMO Payment Gateway

It might be a surprise to learn that the consensus price target was broadly unchanged at JP¥10,135, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic GMO Payment Gateway analyst has a price target of JP¥13,200 per share, while the most pessimistic values it at JP¥8,500. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the GMO Payment Gateway's past performance and to peers in the same industry. The period to the end of 2027 brings more of the same, according to the analysts, with revenue forecast to display 15% growth on an annualised basis. That is in line with its 16% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 3.5% per year. So it's pretty clear that GMO Payment Gateway is forecast to grow substantially faster than its industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for GMO Payment Gateway. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple GMO Payment Gateway analysts - going out to 2029, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with GMO Payment Gateway , and understanding these should be part of your investment process.